41 – 50 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
The risk of distant metastases and cancer-specific survival in men with serum prostate-specific antigen values above 100 ng/ml.
(
- Contribution to journal › Article
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
-
Mark
Clinical Management of Prostate Cancer in Men with BRCA Mutations.
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
The Clinical Impact of Genetic Susceptibility to Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.
(
- Contribution to journal › Article
-
Mark
The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Current routines for transrectal ultrasound-guided prostate biopsy: A web-based survey by the Swedish Urology Network
(
- Contribution to journal › Article
-
Mark
Concordance of Tumor Differentiation Among Brothers with Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
(
- Contribution to journal › Article